Department of Endocrinology, Affiliated Hospital of Integrated Traditional Chinese and Western Medicine, Nanjing University of Chinese Medicine, Nanjing, China.
Eur Rev Med Pharmacol Sci. 2019 Oct;23(19):8551-8559. doi: 10.26355/eurrev_201910_19170.
To investigate the effects of long non-coding ribonucleic acid (lncRNA) metastasis-associated lung adenocarcinoma transcript 1 (MALAT1) on the high glucose-induced proliferation, apoptosis, migration and angiogenesis of endothelial cells and its potential mechanism.
Human umbilical vein endothelial cells (HUVECs) were divided into 3 groups, including control group (medium with 5.5 mmol/L glucose), high glucose group (HG group, medium with 33.5 mmol/L glucose) and lncRNA MALAT1 knockdown group [HG + MALAT1 small interfering RNA (siRNA) group, medium with 33.5 mmol/L glucose]. Cell Counting Kit-8 (CCK-8) assay was performed to observe the proliferation of HUVECs in each group at different time points. Meanwhile, the wound-healing assay was applied to detect the migratory ability of HUVECs in each group at 0 h and 24 h. The apoptosis rate of each group of cells was measured by means of flow cytometry, and the expression of Bcl-2-associated X protein (Bax) was detected via immunofluorescence at the same time. In addition, the amount of neovascularization in each group of cells was observed through the tube formation assay. Finally, Western blotting was utilized to determine the expression level of proteins in phosphatidylinositol 3-kinase (PI3K)/Akt signaling pathway in each group of cells.
Compared with that in the control group, the expression level of lncRNA MALAT1 in the HG group was elevated markedly (p<0.05). The proliferative capacity of HUVECs in the HG group was increased notably after knocking down lncRNA MALAT1 with siRNA (p<0.05). According to wound-healing assay, the knockdown of lncRNA MALAT1 could prominently reverse the declined HUVECs migratory ability induced by high glucose (p<0.05). Flow cytometry results manifested that the apoptosis level of HUVECs in the HG group was increased markedly, but inhibition on lncRNA MALAT1 could lower the apoptosis level evidently (p<0.05). The results of immunofluorescence showed that the expression of Bax in the HG + MALAT1 siRNA group was remarkably lower than that in the HG group (p<0.05). It was revealed in Western blotting that the knockdown of lncRNA MALAT1 could reverse the inhibition of high glucose on the PI3K/Akt signaling pathway in HUVECs (p<0.05).
Inhibiting lncRNA MALAT1 can promote endothelial cell proliferation, migration and angiogenesis and repress endothelial cell apoptosis simultaneously, whose mechanism may be related to the activation of the PI3K/Akt signaling pathway.
探讨长链非编码 RNA(lncRNA)肺腺癌转移相关转录本 1(MALAT1)对高糖诱导的内皮细胞增殖、凋亡、迁移和血管生成的影响及其潜在机制。
将人脐静脉内皮细胞(HUVEC)分为 3 组,包括对照组(含 5.5mmol/L 葡萄糖的培养基)、高糖组(HG 组,含 33.5mmol/L 葡萄糖的培养基)和 lncRNA MALAT1 敲低组[HG+MALAT1 小干扰 RNA(siRNA)组,含 33.5mmol/L 葡萄糖的培养基]。采用细胞计数试剂盒-8(CCK-8)法分别于不同时间点检测各组 HUVEC 的增殖情况。同时,采用划痕愈合实验检测各组 HUVEC 在 0h 和 24h 的迁移能力。采用流式细胞术检测各组细胞的凋亡率,同时通过免疫荧光法检测 Bax 蛋白的表达。此外,通过管形成实验观察各组细胞的新生血管生成情况。最后,采用 Western blot 法检测各组细胞中磷脂酰肌醇 3-激酶(PI3K)/Akt 信号通路相关蛋白的表达水平。
与对照组相比,HG 组 lncRNA MALAT1 的表达水平明显升高(p<0.05)。用 siRNA 敲低 lncRNA MALAT1 后,HG 组 HUVEC 的增殖能力显著增强(p<0.05)。划痕愈合实验结果表明,敲低 lncRNA MALAT1 可显著逆转高糖诱导的 HUVEC 迁移能力下降(p<0.05)。流式细胞术结果表明,HG 组 HUVEC 的凋亡水平明显升高,而抑制 lncRNA MALAT1 可明显降低凋亡水平(p<0.05)。免疫荧光结果显示,HG+MALAT1 siRNA 组 Bax 蛋白的表达明显低于 HG 组(p<0.05)。Western blot 结果表明,敲低 lncRNA MALAT1 可逆转高糖对 HUVEC 中 PI3K/Akt 信号通路的抑制作用(p<0.05)。
抑制 lncRNA MALAT1 可同时促进内皮细胞增殖、迁移和血管生成,抑制内皮细胞凋亡,其机制可能与激活 PI3K/Akt 信号通路有关。